Literature DB >> 8808293

A novel gene, DXS8237E, lies within 20 kb upstream of UBE1 in Xp11.23 and has a different X inactivation status.

M P Coleman1, H J Ambrose, L Carrel, A H Németh, H F Willard, K E Davies.   

Abstract

A novel X-linked gene, DXS8237E, was isolated from human fetal brain cDNA, and its 3' end was mapped to within 20 kb upstream of UBE1 in Xp11.23. A 1.3-kb cDNA for DXS8237E detects homologous sequences in other mammals and a 3-kb mRNA that is widely expressed in human cell lines and mouse tissues. Sequence analysis indicated that the 1.3-kb cDNA contains the 3' end of the DXS8237E gene, but the sequence shows no significant homology to known genes. DXS8237E was shown to be subject to X inactivation in five somatic cell hybrids that contain an inactive human X chromosome but no active homologue. Since UBE1 escapes X inactivation, DXS8237E and UBE1 are the closest mapped genes with discordant X inactivation profiles. Sequences in the vicinity of these two genes may be important determinants of X inactivation status.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8808293     DOI: 10.1006/geno.1996.0022

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  6 in total

1.  Massively parallel sequencing of exons on the X chromosome identifies RBM10 as the gene that causes a syndromic form of cleft palate.

Authors:  Jennifer J Johnston; Jamie K Teer; Praveen F Cherukuri; Nancy F Hansen; Stacie K Loftus; Karen Chong; James C Mullikin; Leslie G Biesecker
Journal:  Am J Hum Genet       Date:  2010-05-06       Impact factor: 11.025

2.  Insight into the role of alternative splicing within the RBM10v1 exon 10 tandem donor site.

Authors:  Sarah J Tessier; Julie J Loiselle; Anne McBain; Celine Pullen; Benjamin W Koenderink; Justin G Roy; Leslie C Sutherland
Journal:  BMC Res Notes       Date:  2015-02-19

Review 3.  RBM10: Harmful or helpful-many factors to consider.

Authors:  Julie J Loiselle; Leslie C Sutherland
Journal:  J Cell Biochem       Date:  2018-01-19       Impact factor: 4.429

4.  A Frameshift RBM10 Variant Associated With TARP Syndrome.

Authors:  Han Daicheng; Xia Shiwen; Zhang Jingxuan; Hu Junbo; Wang Bo
Journal:  Front Genet       Date:  2022-08-04       Impact factor: 4.772

5.  Comprehensive molecular profiling of lung adenocarcinoma.

Authors: 
Journal:  Nature       Date:  2014-07-09       Impact factor: 49.962

Review 6.  RBM10, a New Regulator of p53.

Authors:  Ji Hoon Jung; Hyemin Lee; Shelya X Zeng; Hua Lu
Journal:  Cells       Date:  2020-09-16       Impact factor: 7.666

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.